Literature DB >> 19751401

Dengue hemorrhage in a mouse model.

Betty A Wu-Hsieh1, Yu-Ting Yen, Hsuen-Chin Chen.   

Abstract

Here we summarized our findings in the mouse model of the events that lead to dengue hemorrhage. Immunocompetent mice inoculated intradermally with DENV-2 strain 16681 develop hemorrhage locally or systemically. The incidence and the severity of hemorrhage development are dependent on the size of viral inoculum. The hemorrhage mice exhibit severe thrombocytopenia, prolonged bleeding time, and increased numbers of circulating endothelial cells. In the hemorrhage tissues, there is endothelial damage accompanied by infiltrating macrophages that secret TNF-alpha. The endothelial cells express iNOS and peroxynitrite and undergo apoptosis, indicating RNS and ROS production may lead to cell death. By using mice deficient in iNOS and phox47 and apocynin, we demonstrated that RNS and ROS are important to hemorrhage development after infection by DENV. Our mouse model offers the opportunity to test potential dengue vaccines and therapeutics to treat dengue hemorrhage and to test hemorrhage induction potentials of dengue viral strains.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751401     DOI: 10.1111/j.1749-6632.2009.05053.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  16 in total

Review 1.  Immune-mediated cytokine storm and its role in severe dengue.

Authors:  Anon Srikiatkhachorn; Anuja Mathew; Alan L Rothman
Journal:  Semin Immunopathol       Date:  2017-04-11       Impact factor: 9.623

Review 2.  Endothelial cells in dengue hemorrhagic fever.

Authors:  Anon Srikiatkhachorn; James F Kelley
Journal:  Antiviral Res       Date:  2014-07-12       Impact factor: 5.970

3.  Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor.

Authors:  Susana Orozco; Michael A Schmid; Poornima Parameswaran; Ruben Lachica; Matthew R Henn; Robert Beatty; Eva Harris
Journal:  J Gen Virol       Date:  2012-07-18       Impact factor: 3.891

4.  In vivo infection by a neuroinvasive neurovirulent dengue virus.

Authors:  Myriam Lucia Velandia-Romero; Orlando Acosta-Losada; Jaime E Castellanos
Journal:  J Neurovirol       Date:  2012-07-24       Impact factor: 2.643

5.  VEGFR2 and Src kinase inhibitors suppress Andes virus-induced endothelial cell permeability.

Authors:  Elena E Gorbunova; Irina N Gavrilovskaya; Timothy Pepini; Erich R Mackow
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

Review 6.  New insights into host-pathogen interactions during Entamoeba histolytica liver infection.

Authors:  D M Faust; J Marquay Markiewicz; J Santi-Rocca; N Guillen
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

7.  A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice.

Authors:  Grace K Tan; Jowin K W Ng; Scott L Trasti; Wouter Schul; George Yip; Sylvie Alonso
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

8.  Issues related to recent dengue vaccine development.

Authors:  Eiji Konishi
Journal:  Trop Med Health       Date:  2011-08-06

9.  Dengue type 4 live-attenuated vaccine viruses passaged in vero cells affect genetic stability and dengue-induced hemorrhaging in mice.

Authors:  Hsiang-Chi Lee; Yu-Ting Yen; Wen-Yu Chen; Betty A Wu-Hsieh; Suh-Chin Wu
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

10.  Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model.

Authors:  Sen-Mao Tien; Po-Chun Chang; Yen-Chung Lai; Yung-Chun Chuang; Chin-Kai Tseng; Yu-San Kao; Hong-Jyun Huang; Yu-Peng Hsiao; Yi-Ling Liu; Hsing-Han Lin; Chien-Chou Chu; Miao-Huei Cheng; Tzong-Shiann Ho; Chih-Peng Chang; Shu-Fen Ko; Che-Piao Shen; Robert Anderson; Yee-Shin Lin; Shu-Wen Wan; Trai-Ming Yeh
Journal:  PLoS Pathog       Date:  2022-04-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.